Position in GNLX
as of Mar 31, 2026
· filed May 4, 2026
Position Value
$1,597
-$1,280 QoQ
Shares Held
660
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GNLX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Prudent Man Investment Management, Inc. holds $2,272 across 2 Biotechnology names. GNLX ranks #1 (70.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GNLX |
GENELUX Corp
This page
|
660 | $1,597 | |
| 2 | VYGR |
Voyager Therapeutics, Inc.
|
175 | $675 |
All Filings in GNLX
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,597 | 660 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $2,877 | 660 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $2,772 | 660 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $1,894 | 660 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,782 | 660 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $1,557 | 660 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||